According to the announcement of Harbin Pharmaceutical Co., Ltd., the daily closing price increase deviation value of the company's stock exceeded 20% for 2 consecutive trading days on August 10 and 11, 2026, which was an abnormal fluctuation. From August 7 to 11, it went up and down for three consecutive trading days, with a cumulative increase of 32.96%. The turnover rates for the past 3 days were 10.71%, 5.23%, and 26.95%, respectively. The volume of transactions was significant. By the close of trading on August 10, the company's static price-earnings ratio was 52.38 times, significantly higher than the industry's 28.98 times. After self-inspection, the company's fundamentals have not changed, no important information should be disclosed, and investors are reminded to pay attention to transaction risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.